Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Johnson KCC, Goldstein D, Tharakan J, Quiroga D, Kassem M, Grimm M, Miah A, Vargo C, Berger M, Sudheendra P, Pariser A, Gatti-Mays ME, Williams N, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Tozbikian G, Schnell PM, Cherian MA. Johnson KCC, et al. Among authors: grimm m. Oncol Ther. 2023 Sep;11(3):361-374. doi: 10.1007/s40487-023-00235-6. Epub 2023 Jun 24. Oncol Ther. 2023. PMID: 37354381 Free PMC article.
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer.
Sukumar JS, Quiroga D, Kassem M, Grimm M, Shinde NV, Appiah L, Palettas M, Stephens J, Gatti-Mays ME, Pariser A, Cherian M, Stover DG, Williams N, Van Deusen J, Wesolowski R, Lustberg M, Ramaswamy B, Sardesai S. Sukumar JS, et al. Among authors: grimm m. Breast Cancer Res Treat. 2021 Nov;190(2):183-188. doi: 10.1007/s10549-021-06368-4. Epub 2021 Sep 8. Breast Cancer Res Treat. 2021. PMID: 34498153 Free PMC article. Review.
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies.
Grimm M, Radcliff L, Giles M, Nash R, Holley E, Panda S, Brophy L, Williams N, Cherian M, Stover D, Gatti-Mays ME, Wesolowski R, Sardesai S, Sudheendra P, Reinbolt R, Ramaswamy B, Pariser A. Grimm M, et al. J Clin Med. 2022 Jul 10;11(14):3992. doi: 10.3390/jcm11143992. J Clin Med. 2022. PMID: 35887755 Free PMC article. Review.
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
Mezzanotte JN, Grimm M, Shinde NV, Nolan T, Worthen-Chaudhari L, Williams NO, Lustberg MB. Mezzanotte JN, et al. Among authors: grimm m. Curr Treat Options Oncol. 2022 Jan;23(1):29-42. doi: 10.1007/s11864-021-00926-0. Epub 2022 Feb 15. Curr Treat Options Oncol. 2022. PMID: 35167004 Free PMC article. Review.
Axillary Management: How Much Is Too Much?
Owusu-Brackett N, Facer B, Quiroga D, Pariser A, Grimm M, Beyer S, Jhawar S, Oppong BA. Owusu-Brackett N, et al. Among authors: grimm m. Curr Oncol Rep. 2024 May 15. doi: 10.1007/s11912-024-01539-0. Online ahead of print. Curr Oncol Rep. 2024. PMID: 38748364 Review.
[Advancing standards for the development of evidence-based health information for consumers: Needs and priorities among members of the Network for Evidence-based Medicine].
Büchter RB, Albrecht M, Grimm M, Seelig M, Steckelberg A, Rahn AC. Büchter RB, et al. Among authors: grimm m. Z Evid Fortbild Qual Gesundhwes. 2024 May 13:S1865-9217(24)00059-X. doi: 10.1016/j.zefq.2024.03.011. Online ahead of print. Z Evid Fortbild Qual Gesundhwes. 2024. PMID: 38744602 German.
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J; TITAN-TCC Study Group. Grimm MO, et al. JAMA Oncol. 2024 May 9:e240938. doi: 10.1001/jamaoncol.2024.0938. Online ahead of print. JAMA Oncol. 2024. PMID: 38722641
1,121 results